entertainment -WSS

entertainment

author：comprehensive 2025-09-06 03:33:24 - browse：89389

Three boxes of Wegovy stands in a line — coverage from STAT — Steffen Trumpf/picture alliance/Getty Images

LONDON — Starting in the new year, a team of researchers in the U.K. and Denmark will begin recruiting patients for a study driven by a pressing question in medicine: How should new obesity medications be incorporated into regular practice?

Trials have demonstrated that the powerful drugs can help people shed weight in dramatic ways, but clinicians are still trying to sort out how to best use them. The medicines, after all, are pricey, come with side effects, and won’t work for everyone. And despite the excitement around these drugs, known as GLP-1s, some people might prefer or see better results with the other approaches that have long been the foundation of obesity treatment, from diet to surgery.

“These drugs clearly are very effective, and that is fantastic,” said Susan Jebb, a professor of diet and population health at the University of Oxford and one of the leaders of the project. “But we have other options for treating obesity. What we need to do now in research is understand which treatments, for which patients, at which stage of their disease.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Patient advocates debate FDA's accelerated approval process

WSS

Methadone treatment changes are coming. Do they go far enough?

Gene editing the human germline: What are the risks?

Asbestos, a deadly carcinogen, banned by EPA

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

Vertex Pharmaceuticals may move headquarters in Boston

Will generative AI in health care meet the fate of IBM's Dr. Watson?

hotspot

entertainment

focus

Duchenne breakthrough therapy leaves behind pioneering families

Colonoscopy prep: Liquid

State Dept. review finds Biden bears some blame for Afghanistan failures

Positive childhood experiences can help future health

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Creating egg and sperm cells from stem cells raises ethical issues

Tori Bowie and the unacceptable rates of Black maternal death

CVS Caremark has created a new ploy: the drug ‘rebate credit’

Jerome Adams on the need for new antivirals for Covid

Eliminate the waiting period for sterilization covered by Medicaid

hotspot

Decaf coffee targeted by food safety group under obscure FDA rule

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

Why the world’s most expensive drug might be worth the price

Why the world’s most expensive drug might be worth the price

Intermittent fasting comes with a heart risk? Not so fast

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

hotspot

hotspot

hotspot

focus